Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuko Sakai

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Clinical and Vaccine Immunology : CVI|February 25, 2011
Seroprevalence of pandemic 2009 (H1N1) influenza A virus among schoolchildren and their parents in Tokyo, JapanKiyoko Iwatsuki-Horimoto, Taisuke Horimoto, Daisuke Tamura, et al.
Plos Pathogens|September 24, 2010
The HA and NS genes of human H5N1 influenza A virus contribute to high virulence in ferretsHirotaka Imai, Kyoko Shinya, Ryo Takano, et al.
Science Advances|March 6, 2021
Longitudinal antibody repertoire in "mild" versus "severe" COVID-19 patients reveals immune markers associated with disease severity and resolutionSupriya Ravichandran, Youri Lee, Gabrielle Grubbs, et al.
Emerging Infectious Diseases|June 19, 2018
Diversity of Influenza A(H5N1) Viruses in Infected Humans, Northern Vietnam, 2004-2010Hirotaka Imai, Jorge M Dinis, Gongxun Zhong, et al.
Nature|November 17, 2006
Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptorsShinya Yamada, Yasuo Suzuki, Takashi Suzuki, et al.
Nature|November 2, 2022
Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodentsRyuta Uraki, Peter J Halfmann, Shun Iida, et al.
Iscience|July 14, 2023
Differences among epitopes recognized by neutralizing antibodies induced by SARS-CoV-2 infection or COVID-19 vaccinationShinya Yamamoto, Seiya Yamayoshi, Mutsumi Ito, et al.
Nature Microbiology|November 27, 2019
Influenza A variants with reduced susceptibility to baloxavir isolated from Japanese patients are fit and transmit through respiratory dropletsMasaki Imai, Makoto Yamashita, Yuko Sakai-Tagawa, et al.
Nature Communications|March 24, 2023
Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolatesRyuta Uraki, Shun Iida, Peter J Halfmann, et al.
Plos Pathogens|August 12, 2010
Biological and structural characterization of a host-adapting amino acid in influenza virusShinya Yamada, Masato Hatta, Bart L Staker, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Clinical and Vaccine Immunology : CVI|February 25, 2011
Seroprevalence of pandemic 2009 (H1N1) influenza A virus among schoolchildren and their parents in Tokyo, JapanKiyoko Iwatsuki-Horimoto, Taisuke Horimoto, Daisuke Tamura, et al.
Plos Pathogens|September 24, 2010
The HA and NS genes of human H5N1 influenza A virus contribute to high virulence in ferretsHirotaka Imai, Kyoko Shinya, Ryo Takano, et al.
Science Advances|March 6, 2021
Longitudinal antibody repertoire in "mild" versus "severe" COVID-19 patients reveals immune markers associated with disease severity and resolutionSupriya Ravichandran, Youri Lee, Gabrielle Grubbs, et al.
Emerging Infectious Diseases|June 19, 2018
Diversity of Influenza A(H5N1) Viruses in Infected Humans, Northern Vietnam, 2004-2010Hirotaka Imai, Jorge M Dinis, Gongxun Zhong, et al.
Nature|November 17, 2006
Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptorsShinya Yamada, Yasuo Suzuki, Takashi Suzuki, et al.
Nature|November 2, 2022
Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodentsRyuta Uraki, Peter J Halfmann, Shun Iida, et al.
Iscience|July 14, 2023
Differences among epitopes recognized by neutralizing antibodies induced by SARS-CoV-2 infection or COVID-19 vaccinationShinya Yamamoto, Seiya Yamayoshi, Mutsumi Ito, et al.
Nature Microbiology|November 27, 2019
Influenza A variants with reduced susceptibility to baloxavir isolated from Japanese patients are fit and transmit through respiratory dropletsMasaki Imai, Makoto Yamashita, Yuko Sakai-Tagawa, et al.
Nature Communications|March 24, 2023
Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolatesRyuta Uraki, Shun Iida, Peter J Halfmann, et al.
Plos Pathogens|August 12, 2010
Biological and structural characterization of a host-adapting amino acid in influenza virusShinya Yamada, Masato Hatta, Bart L Staker, et al.
Pageof 10